Stock 002424 GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Guizhou Bailing Group Pharmaceutical Co., Ltd.

Equities

002424

CNE100000PY3

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-08 EDT 		5-day change 1st Jan Change
5.26 CNY -5.05% Intraday chart for Guizhou Bailing Group Pharmaceutical Co., Ltd. -18.58% -35.14%
05-03 Large-Scale Equipment Renewals Seen to Raise Demand for Chinese High-End Steel Products, Trade Body Says MT
05-02 China to Tweak Production Limits for Steel as Industry Faces Low Prices, Oversupply MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Large-Scale Equipment Renewals Seen to Raise Demand for Chinese High-End Steel Products, Trade Body Says
MT
China to Tweak Production Limits for Steel as Industry Faces Low Prices, Oversupply
MT
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.
CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Bailing Group Pharma Gets Green Light for Clinical Trial of New Hepatitis B Drug
MT
China steel association says EU carbon tax a new trade barrier, calls for more talks
RE
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
China’s Steel Consumption Falls 1.5% in January-September Period
MT
China steel supply needs adjusting, industry official says
RE
EU to launch first phase of world-first CO2 border tax
RE
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.
CI
Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 9, 2023 has closed with 12,096,900 shares, representing 0.87% for CNY 100.01 million.
CI
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.
CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. Announces Management Appointments
CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.
CI
Zhejiang Futures Co., Ltd completed the acquisition of 11.17% stake in Guizhou Bailing Group Pharmaceutical Co., Ltd. from Jiang Wei.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002424 Stock
  4. News Guizhou Bailing Group Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW